Straumann USA LLC

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$44Mgeneral payments (2019-2025)
$9,018research payments (2019-2025)
52,622clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $3.6M
2020 $3.8M
2021 $7.1M
2022 $6.6M
2023 $6.8M
2024 $7.5M
2025 $8.2M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Specialties it works with most

Dentist $11M
General Practice (Dentist) $9.3M
Oral and Maxillofacial Surgery $9.2M
Prosthodontics $4.8M
Periodontics $4.7M
Orthodontics and Dentofacial Orthopedics $2.6M

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Edmond Bedrossian San Francisco, CA Oral and Maxillofacial Surgery $3,711,410.52
Todd Engel Ladera Ranch, CA Dentist $3,384,547.06
Aleksander Jovanovic Los Angeles, CA Periodontics $1,064,074.31
Robert Vogel Palm Beach Gardens, FL General Practice (Dentist) $1,039,538.95
Yan Kalika San Francisco, CA Orthodontics and Dentofacial Orthopedics $819,697.41
James Mah Las Vegas, NV Orthodontics and Dentofacial Orthopedics $819,327.08
Wael Att Boston, MA Prosthodontics $776,395.26
David Rallis Rochester, MN Oral and Maxillofacial Surgery $776,092.50
Sean Mohtashami Las Vegas, NV Dentist $603,081.18
Jonathan Dawson Charlotte, NC Prosthodontics $497,784.79

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.